Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

COVID-19's impact on women and domestic violence

Date added: 06 May 2020

Support for early-stage research projects exploring women, victimisation, and domestic violence in the COVID-19 crisis. Research projects that focus on developing and developed nations are welcome.

Amount
$20.000 (USD)
Agency or Funder
The National Bureau of Economic Research
Eligibility (if available)

Applicants must be current affiliates of an academic institution

Date application deadline

Insights into COVID-19 and the Global Compact for Migration

Date added: 08 May 2020

Researcher required to provide insight into how the Global Compact for Migration was used in the COVID-19 crisis, what lessons can be learnt from it, and what implications the pandemic may have for the future of the agreement.

Amount
Unspecified
Agency or Funder
Mixed Migration Centre
Eligibility (if available)

Consultants with 3 to 4 years of experience

Date application deadline

Understanding the impact of COVID-19 on people living with HIV

Date added: 29 Apr 2020

Priority areas include epidemiology, health care system management, and biomarkers indicative of disease susceptibility, severity and progression.

Amount
£1.5M
Agency or Funder
ViiV Healthcare
Eligibility (if available)

Applicants must be affiliated with a clinical institution

Foreign participation? (where known)
Yes
Date application deadline

Patient-centred comparative clinical effectiveness research

Date added: 13 May 2020

Research should address the impact of the pandemic on vulnerable populations and how COVID-19 has altered healthcare delivery and healthcare workers' wellbeing, management and training.

Amount
Up to €5M USD
Agency or Funder
Patient-Centered Outcomes Research Institute
Eligibility (if available)

Private and public sector organisations, education and research institutions, hospitals and healthcare institutions

Foreign participation? (where known)
Yes
Date application deadline

Innovative solutions to social issues created by COVID-19

Date added: 11 May 2020

Grants for projects that will build lasting solutions for protecting vulnerable populations and key workers affected by the COVID-19 crisis.

Amount
$1 M (USD)
Agency or Funder
The Booz Allen Foundation
Eligibility (if available)

Individuals and teams from universities, non-profits, startups, and SMEs. Principal investigator must be a US citizen with a US bank account.

Foreign participation? (where known)
Yes
Date application deadline

Support for projects seeking to mitigate the health consequences of the coronavirus (COVID-19) epidemic in Denmark

Date added: 23 Apr 2020

Support for projects seeking to mitigate the health consequences of the coronavirus (COVID-19) epidemic in Denmark

Amount
DKK 50M
Agency or Funder
Novo Nordisk Foundation
Eligibility (if available)

Public institutions / authorities or private non-profit organizations (eg NGOs) in Denmark participating in the fight against the coronavirus epidemic

Foreign participation? (where known)
No
Date application deadline

Long term impact of COVID-19

Date added: 15 Jun 2020

Research must address long-term impacts of COVID-19 to support recovery and learning for health and care services, and to mitigate the impact of any further waves of infection.

Amount
Not specified
Agency or Funder
National Institute for Health Research
Eligibility (if available)

Any UK institution

Date application deadline

COVID-19 in vulnerable populations, its long-term effect, and the effectiveness of remdesivir

Date added: 06 Jul 2020

Projects lasting up to 9 months should collect data on the clinical course and outcome of COVID-19 in vulnerable populations, investigate long-term consequences of COVID-19 in patients, or test the safety and effectiveness of remdesivir in treatin

Amount
Up to $250,000 USD
Agency or Funder
GILEAD
Foreign participation? (where known)
Yes
Date application deadline